Stock Events

Stock Events

Morphosys 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Oct 21
€0.27
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals competes in the biotech space, focusing on monoclonal antibodies, a key area for Morphosys.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotechnology firm with a strong emphasis on innovative therapeutics, directly competing with Morphosys in drug development.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is involved in the discovery, development, and commercialization of therapeutics, sharing a market space with Morphosys.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on neurological diseases and has a portfolio that overlaps with Morphosys's therapeutic areas.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that operates in R&D of novel therapeutics, including areas where Morphosys is active.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a major player in biotechnology and pharmaceuticals, competing with Morphosys in oncology and immunology.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a global biopharmaceutical company, with a competitive edge in cancer and immune system-related diseases.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a global pharmaceutical corporation with a broad range of products that compete with Morphosys's treatments.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie operates in similar therapeutic areas as Morphosys, particularly in immunology and oncology, making it a direct competitor.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the same therapeutic areas as Morphosys, including immunology and oncology.

About

There is no Profile data available for MOR.SG.
Show more...
CEO
Country
Germany
ISIN
US6177602025
WKN
000A2JJ5S

Listings

MU
DE
MOR2.MU
STU
DE
MOR.STU
STU
DE
MOR2.STU

0 Comments

Share your thoughts

FAQ

What is Morphosys stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Morphosys stocks are traded under the ticker MOR2.STU.
Does Morphosys pay dividends?▼
Yes, MOR2.STU dividends are paid annual. The last dividend per share was 0.27 EUR. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Morphosys located?▼
Morphosys operates in the Materials sector.
When did Morphosys complete a stock split?▼
Morphosys has not had any recent stock splits.